Come up with a name for your new list and we'll add to it:
Interleukin Genetics raised a round of funding on , . Investors include
Bay City Capital.
Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic …